SAN DIEGO - Marcos Frank, PhD, associate professor of Neuroscience at the University of Pennsylvania School of Medicine, presented information on early brain development and the importance of sleep during early life when the brain is rapidly maturing and highly changeable, at the 2010 American Association for the Advancement of Science meeting in San Diego this week.
Building on his research indicating that the brain during sleep is fundamentally different from the brain during wakefulness, Frank has found that cellular changes in the sleeping brain may promote the formation of memories. "This is the first real direct insight into how the brain, on a cellular level, changes the strength of its connections during sleep," Frank says.
When an animal goes to sleep it's like a switch is thrown, and everything is turned on that's necessary for making synaptic changes that form the basis of memory formation. The team used an animal model of cortical plasticity – the making and breaking of neural connections in response to life experiences.
They found that once the brain is triggered to reorganize its neural networks in wakefulness (by visual deprivation, for instance), intra- and intercellular communication pathways engage, setting a series of enzymes into action within the reorganizing neurons during sleep. The key cellular player in this process is a molecule called N-methyl D-aspartate receptor (NMDAR), which acts like a combination listening post and gate-keeper. It both receives extracellular signals in the form of glutamate and regulates the flow of calcium ions into cells. As soon as the animal had a chance to sleep, we saw all the machinery of memory start to engage, notes Frank.
The Frank lab aims to relate these findings about memory formation at the molecular level to why humans need sleep and why they are so affected by the lack of it.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.